(HELE) Helen of Troy - Ratings and Ratios
Hydration Bottles, Kitchen Tools, Hair Appliances, Water Filters, Air Purifiers
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 56.5% |
| Value at Risk 5%th | 75.7% |
| Relative Tail Risk | -18.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.39 |
| Alpha | -84.65 |
| CAGR/Max DD | -0.46 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.564 |
| Beta | 1.262 |
| Beta Downside | 1.492 |
| Drawdowns 3y | |
|---|---|
| Max DD | 87.89% |
| Mean DD | 43.49% |
| Median DD | 34.36% |
Description: HELE Helen of Troy October 23, 2025
Helen of Troy Ltd (NASDAQ: HELE) designs, manufactures and markets a broad portfolio of consumer products across two primary segments – Home & Outdoor and Beauty & Wellness – serving markets in North America, Europe, the Middle East, Africa, APAC and Latin America. The Home & Outdoor segment includes food-storage and kitchen tools, insulated beverageware, travel and outdoor packs, and related accessories, while the Beauty & Wellness segment covers hair-care appliances, grooming tools, and health-monitoring devices such as thermometers and air-purifiers.
The company distributes its brands (OXO, Hydro Flask, Osprey, PUR, etc.) through a mix of mass-merchandisers, specialty retailers, e-commerce platforms and direct-to-consumer channels. In FY 2023 HELE reported revenue of roughly $2.1 billion, up about 8 % YoY, with an operating margin near 12 %, reflecting strong pricing power in premium-priced segments and cost-discipline in its supply chain.
Key macro drivers include continued consumer spending on home-improvement and wellness products, the shift toward e-commerce which now accounts for ~30 % of total sales, and rising demand for sustainable, reusable containers and health-monitoring devices – trends that have historically out-performed the broader household-appliances sub-industry. However, inflationary pressure on raw-material costs and potential supply-chain disruptions remain material risks.
If you want to dig deeper into HELE’s valuation multiples and forward-looking growth assumptions, a quick look at ValueRay’s analyst toolkit can provide the data you need without the fluff.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-658.8m TTM) > 0 and > 6% of Revenue (6% = 109.2m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -3.41pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.33% (prev 20.31%; Δ 1.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 91.2m > Net Income -658.8m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (23.0m) change vs 12m ago 0.53% (target <= -2.0% for YES) |
| Gross Margin 47.30% (prev 47.80%; Δ -0.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 68.84% (prev 67.00%; Δ 1.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.99 (EBITDA TTM -110.3m / Interest Expense TTM 55.1m) >= 6 (WARN >= 3) |
Altman Z'' 1.78
| (A) 0.16 = (Total Current Assets 938.1m - Total Current Liabilities 550.0m) / Total Assets 2.41b |
| (B) 0.23 = Retained Earnings (Balance) 552.4m / Total Assets 2.41b |
| (C) -0.06 = EBIT TTM -164.6m / Avg Total Assets 2.64b |
| (D) 0.37 = Book Value of Equity 549.2m / Total Liabilities 1.48b |
| Total Rating: 1.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 26.78
| 1. Piotroski 2.50pt |
| 2. FCF Yield 5.40% |
| 3. FCF Margin 4.13% |
| 4. Debt/Equity 1.01 |
| 5. Debt/Ebitda -8.26 |
| 6. ROIC - WACC (= -11.53)% |
| 7. RoE -48.22% |
| 8. Rev. Trend -72.66% |
| 9. EPS Trend -70.38% |
What is the price of HELE shares?
Over the past week, the price has changed by -3.71%, over one month by +16.92%, over three months by -10.47% and over the past year by -69.31%.
Is HELE a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HELE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.3 | 42.9% |
| Analysts Target Price | 29.3 | 42.9% |
| ValueRay Target Price | 11.7 | -42.9% |
HELE Fundamental Data Overview December 16, 2025
P/E Forward = 4.9702
P/S = 0.2657
P/B = 0.5221
P/EG = 0.9718
Beta = 0.821
Revenue TTM = 1.82b USD
EBIT TTM = -164.6m USD
EBITDA TTM = -110.3m USD
Long Term Debt = 871.3m USD (from longTermDebt, last quarter)
Short Term Debt = 21.9m USD (from shortTermDebt, last quarter)
Debt = 932.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 910.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.39b USD (483.6m + Debt 932.7m - CCE 25.0m)
Interest Coverage Ratio = -2.99 (Ebit TTM -164.6m / Interest Expense TTM 55.1m)
FCF Yield = 5.40% (FCF TTM 75.1m / Enterprise Value 1.39b)
FCF Margin = 4.13% (FCF TTM 75.1m / Revenue TTM 1.82b)
Net Margin = -36.20% (Net Income TTM -658.8m / Revenue TTM 1.82b)
Gross Margin = 47.30% ((Revenue TTM 1.82b - Cost of Revenue TTM 959.1m) / Revenue TTM)
Gross Margin QoQ = 44.16% (prev 47.09%)
Tobins Q-Ratio = 0.58 (Enterprise Value 1.39b / Total Assets 2.41b)
Interest Expense / Debt = 1.52% (Interest Expense 14.2m / Debt 932.7m)
Taxrate = 6.38% (-21.0m / -329.7m)
NOPAT = -154.1m (EBIT -164.6m * (1 - 6.38%)) [loss with tax shield]
Current Ratio = 1.71 (Total Current Assets 938.1m / Total Current Liabilities 550.0m)
Debt / Equity = 1.01 (Debt 932.7m / totalStockholderEquity, last quarter 926.3m)
Debt / EBITDA = -8.26 (negative EBITDA) (Net Debt 910.3m / EBITDA -110.3m)
Debt / FCF = 12.12 (Net Debt 910.3m / FCF TTM 75.1m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -27.37% (Net Income -658.8m / Total Assets 2.41b)
RoE = -48.22% (Net Income TTM -658.8m / Total Stockholder Equity 1.37b)
RoCE = -7.36% (EBIT -164.6m / Capital Employed (Equity 1.37b + L.T.Debt 871.3m))
RoIC = -6.94% (negative operating profit) (NOPAT -154.1m / Invested Capital 2.22b)
WACC = 4.58% (E(483.6m)/V(1.42b) * Re(10.67%) + D(932.7m)/V(1.42b) * Rd(1.52%) * (1-Tc(0.06)))
Discount Rate = 10.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.81%
[DCF Debug] Terminal Value 59.61% ; FCFE base≈120.3m ; Y1≈79.0m ; Y5≈36.1m
Fair Price DCF = 21.29 (DCF Value 490.2m / Shares Outstanding 23.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -70.38 | EPS CAGR: -49.26% | SUE: -4.0 | # QB: 0
Revenue Correlation: -72.66 | Revenue CAGR: -9.39% | SUE: 0.84 | # QB: 0
EPS current Year (2026-02-28): EPS=4.03 | Chg30d=-0.489 | Revisions Net=-3 | Growth EPS=-43.7% | Growth Revenue=-7.6%
EPS next Year (2027-02-28): EPS=4.21 | Chg30d=-0.782 | Revisions Net=-3 | Growth EPS=+4.2% | Growth Revenue=+2.0%
Additional Sources for HELE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle